Last updated: 2026-10-01 08:33:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
DataMeds AI, Inc. (MEDS) operates in the WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES sector and is listed on NASDAQ. The stock is currently priced at $3.31, with a market capitalization of $11.74M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.82 to $12.31. This page covers its latest market performance, valuation, price trends and company information.
$11.74M | |
$3.21 | |
$504.00 | |
$0.82 | |
$3.17 | |
13.23K | |
6.68M | |
-- | |
$12.31 | |
$0.82 | |
-- | |
-- |
DataMeds AI, Inc. (MEDS) is trading at $3.31 in pre-market trading as of 2026-10-01 08:31:00, up 4.38% ($0.14) from the previous close of $3.17
Pre-market trading shows how investors are pricing MEDS before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, DataMeds AI, Inc. (MEDS) moved from $4.28 to $3.31, representing a decline of 22.60% ($0.97).
The stock traded between $3.01 and $5.38 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 5.60 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 21.6%
MEDS is currently trading at $3.31, placing it 21.6% of the way from its 52-week low of $0.82 to its 52-week high of $12.31. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
DataMEDS AI Inc is a healthcare technology and pharmaceutical logistics company. The group simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. Its solutions provide a single, integrated platform for pharmacies, wholesale distribution, and a fulfillment network focused on Independent Pharmacies and Specialty Lite medications.
| Industry | WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of DataMeds AI, Inc. (MEDS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.